Alghasham Abdullah A
Department of Pharmacology and Therapeutics, College of Medicine, Qassim University, Buraidah, Saudi Arabia.
Ann Saudi Med. 2009 Jan-Feb;29(1):24-9. doi: 10.4103/0256-4947.51819.
Physicians play a key role in generic drug prescribing, but their behavior is affected by many determinants. We examined physician practices and attitudes and other factors influencing the prescription of generic drugs.
A self-administered questionnaire was used to collect information from a random sample of physicians from different settings in central Saudi Arabia. Data were analyzed to describe all variables and test any significant difference between groups of physicians.
The study included 772 physicians from different affiliations. The majority of physicians (n=741, 96%) reported that they knew enough about the therapeutic value of generic drugs. The majority (75%) reported that they knew the price differences, and this knowledge helped 72% of them to switch to generic prescription medication. Most physicians (79%) support generic substitution, but they indicated that there are certain clinical situations where they prefer to use brand name drugs. Physicians reported receiving visits and samples more frequently from representatives of brand name companies. Physicians did not report a significant difference in pressure from patients to prescribe either generic or brand drugs. Most physicians had a positive attitude towards the government role in assuring the quality of local drug products (80%) and in enforcing physicians to prescribe generic drugs (85%).
Physicians face competing forces to prescribe either brand name or generic drugs. The majority support generic drug substitution. There are multiple factors that support prescription of generic drugs.
医生在开具非专利药品处方方面发挥着关键作用,但其行为受到多种因素的影响。我们研究了医生的做法、态度以及影响非专利药品处方的其他因素。
采用自填式问卷,从沙特阿拉伯中部不同医疗机构的医生中随机抽样收集信息。对数据进行分析,以描述所有变量,并检验不同医生群体之间的任何显著差异。
该研究纳入了772名来自不同机构的医生。大多数医生(n = 741,96%)报告称他们对非专利药品的治疗价值了解充分。大多数(75%)报告称他们知道价格差异,并且这一认知帮助其中72%的医生改用非专利处方药物。大多数医生(79%)支持非专利药品替换,但他们表示在某些临床情况下更倾向于使用品牌药。医生报告称,他们更频繁地接待品牌药公司代表的来访并收到其提供的样品。医生并未报告患者在开具非专利药或品牌药方面施加的压力存在显著差异。大多数医生对政府在确保当地药品质量(80%)以及强制医生开具非专利药品(85%)方面所发挥的作用持积极态度。
医生在开具品牌药或非专利药处方上面临相互竞争的力量。大多数医生支持非专利药品替换。有多种因素支持非专利药品的处方开具。